© Asian Pacific Society of Nephrology
Edited By: Peter G. Kerr
Impact Factor: 1.688
ISI Journal Citation Reports © Ranking: 2012: 38/73 (Urology & Nephrology)
Online ISSN: 1440-1797
Thank you for your interest in Nephrology. Please consult the following instructions to help you prepare your manuscript, and feel free to contact us with any questions. To ensure fast peer review and publication, manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review. We are looking forward to your submission.
1. AIMS AND SCOPE
Nephrology is the official journal of the Asian Pacific Society of Nephrology, and publishes manuscripts of international interest describing original research concerned with clinical and experimental aspects of nephrology. We welcome submissions in the forms of original research articles, brief communications, instructive cases and letters to the editor and solicit review articles and editorials.
Frequency: 12 times per year
2. REVIEW PROCESS
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor. Final acceptance or rejection rests with the Editorial Board, who reserves the right to refuse any material for publication.
Manuscripts should be written so that they are intelligible to the professional reader who is not a specialist in the particular field. They should be written in a clear, concise, direct style. Where contributions are judged as acceptable for publication on the basis of scientific content, the Editor and the Publisher reserve the right to modify typescripts to eliminate ambiguity and repetition and improve communication between author and reader. If extensive alterations are required, the manuscript will be returned to the author for revision.
3. MANUSCRIPT CATEGORIES
i. Original Articles
Word limit: 4,000 words maximum including abstract and references
Abstract: 250 words maximum and must include subheadings
References: In general, less than 30.
Figures/Tables: Total of no more than 8 figures and tables.
Description: Full-length reports of current research in either basic or clinical science.
ii. Brief Communications
Word limit: 2,000 words maximum including abstract and references
Abstract: 250 words maximum, unstructured
References: In general, less than 20
Figures/Tables: Total of no more than 3 figures and tables
Description: Brief communications of exceptional merit, both clinical and experimental, may be given rapid publication.
iii. Review Articles
Word limit: 4,000 words maximum including abstract and references
Abstract: 250 words maximum, unstructured
References: no limit
Figures/Tables: Total of no more than 8 figures and tables.
Description: Reviews are comprehensive analyses of specific topics. They are usually submitted upon invitation by the Editors. Both solicited and unsolicited review articles will undergo peer review prior to acceptance.
iv. Letters to the Editor
Word limit: 500 words maximum
Abstract: not required
References: 5 maximum
Figures/Tables: 1 maximum
Description: Letters must offer perspective to content published in Nephrology or information critical to a certain area. A Letter must reference the original source, and a Response to a Letter must reference the Letter in the first few paragraphs. Letters can use an arbitrary title, but a Response must cite the title of the Letter: e.g. Response to [title of Letter]. This ensures that readers can track the line of discussion.
v. Correspondence (Instructive Cases)
Word limit: 500 word maximum including references or 400 words maximum with one table or figure
References: 5 maximum
Figures/Tables: 1 single panel figure or 1 table
Instructive Cases should be submitted as Correspondence and will be published in the Correspondence section. Items in the Correspondence section should not contain an abstract, keywords or section headings. Contributions to this section will not undergo peer review but will be assessed by the Editorial team.
vi. Editorials (only by invitation of Editors).
Word limit: 1,000 words maximum
Abstract: no abstract required for this manuscript type
References: 5 maximum
Description: Proposals for Editorials may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration.
Manuscripts must contain a statement to the effect that all human studies have been reveiwed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 2000 Declaration of Helsinki as well as the Declaration of Istanbul 2008. It should also be state clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under the study should be omitted.
Reports of animal experiments must state that the 'Principles of Laboratory animal care' NIH publication Vol 25, No. 28 revised 1996; http://grants.nih.gov/grants/guide/notice-files/not96-208.html) were followed, as well as specific national laws (e.g. the current version of the German Law on the Protection of Animals) where applicable.
5. CLINICAL TRIAL REGISTRATION
Nephrology requires that the clinical trials submitted for its consideration are registered in a publicly accessible database. Authors should include the name of the trial register and their clinical trial registration number in the Acknowledgements section of their manuscript. If you wish the editor[s] to consider an unregistered trial, please explain briefly why the trial has not been registered.
6. RANDOMIZED CONTROLLED TRIALS
Reporting of randomized controlled trials should follow the guidelines of The CONSORT Statement: http://www.consort-statement.org
Authors publishing in the Journal will be asked to sign an Exclusive Licence Form. In signing the form it is assumed that authors have obtained permission to use any copyrighted or previously published material. All authors must read and agree to the conditions outlined in the form, and must sign the form or agree that the corresponding author can sign on their behalf. Articles cannot be published until a signed form has been received. Authors can download the form here.
8. STYLE OF THE MANUSCRIPT
Manuscripts should follow the style of the Vancouver agreement detailed in the International Committee of Medical Journal Editors’ revised ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication’, as presented at http://www.ICMJE.org/.
Spelling. The Journal uses UK spelling and authors should therefore follow the latest edition of the Concise Oxford Dictionary.
Units. All measurements must be given in SI or SI-derived units. Please go to the Bureau International des Poids et Mesures (BIPM) website at http://www.bipm.fr for more information about SI units.
Abbreviations. Abbreviations should be used sparingly – only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
Trade names. Chemical substances should be referred to by the generic name only. Trade names should not used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.
Genetic nomenclature. Standard genetic nomenclature should be used. For further information, including relevant websites, authors should refer to the genetic nomenclature guide in Trends in Genetics (Elsevier Science, 1998).
Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345.’
Addresses are as follows:
DNA Data Bank of Japan (DDBJ) http://www.ddbj.nig.ac.jp
EMBL Nucleotide Sequence Submissions http://www.ebi.ac.uk
9. STRUCTURE OF THE MANUSCRIPT
The length of manuscripts must adhere to the specifications under the section Manuscript Categories.
Manuscripts submitted as Original Articles, Review Articles and Brief Communications, should be presented in the following order:
(i) title page, (ii) abstract and key words, (iii) text, (iv) acknowledgments, (v) references, (vi) supporting information, (vii) figure legends, (viii) tables (each table complete with title and footnotes) and (ix) figures. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
The title page should contain (i) the title of the paper, (ii) the full names of the authors and (iii) the addresses of the institutions at which the work was carried out together with (iv) the full postal and email address, plus facsimile and telephone numbers, of the author to whom correspondence about the manuscript should be sent. The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.
The title should be short, informative and contain the major key words. Do not use abbreviations in the title. A short running title (less than 40 characters) should also be provided.
Abstract and key words
Original articles must have a structured abstract that states in 250 words or fewer the purpose, basic procedures, main findings and principal conclusions of the study. Divide the abstract with the headings: Aim, Methods, Results, Conclusion. Review Articles and Brief Communications should have an unstructured abstract of 250 words or fewer. The abstract should not contain abbreviations or references.
Five key words, for the purposes of indexing, should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at http://www.nlm.nih.gov/mesh/meshhome.html.
The source of financial grants and other funding must be acknowledged, including a frank declaration of the authors’ industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Personal thanks and thanks to anonymous reviewers are not appropriate.
Conflict of Interest
All authors are asked to sign a Competing Interests and Acknowledgment Statement on submission of their manuscript.
The Vancouver system of referencing should be used (examples are given below). In the text, references should be cited using superscript Arabic numerals in the order in which they appear. If cited in tables or figure legends, number according to the first identification of the table or figure in the text.
In the reference list, cite the names of all authors when there are six or fewer; when seven or more, list the first three followed by et al. Do not use ibid. or op cit. Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. Smith A, 2000, unpublished data). All citations mentioned in the text, tables or figures must be listed in the reference list.
Names of journals should be abbreviated in the style used in Index Medicus.
Authors are responsible for the accuracy of the references.
We recommend the use of a tool such as Reference Manager for reference management and formatting.
Reference Manager reference styles can be searched for here:wiley
1 Soter NA, Wasserman SI, Austen KF. Cold urticaria: Release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge. N. Engl. J. Med. 1976; 294: 687–90.
2 Kaufmann HE, Baron BA, McDonald MB, Wlatman SR (eds). The Cornea, 2nd edn. New York: Churchill Livingstone, 1998.
Chapter in a Book
3 McEwen WK, Goodner IK. Secretion of tears and blinking. In: Davidson H (ed). The Eye, Vol 3, 2nd edn. New York: Academic Press, 1969; 34–78.
4 Cancer-Pain.org [homepage on the internet]. New York: Association of Cancer Online Resources, Inc.; c2000–01 [updated 2002 Maylb; cited 2000 Jul 9]. Available from:http://www.cancer-pain.org/.
Tables should be self-contained and complement, but not duplicate, information contained in the text. Number tables consecutively in the text in Arabic numerals. Type tables on a separate page with the legend above. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. Vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.
All illustrations (line drawings and photographs) are classified as figures. Figures should be cited in consecutive order in the text. Magnifications should be indicated using a scale bar on the illustration. If figures have been reproduced from another source, a letter from the copyright holder (usually the Publisher), stating authorization to reproduce the material, must be attached to the covering letter.
Figures should be sized to fit within the column (81 mm), intermediate (118 mm) or the full text width (169 mm).
Line figures should be sharp, black and white graphs or diagrams, drawn professionally or with a computer graphics package. Lettering must be included and should be sized to be no larger than the journal text.
Figure legends. Type figure legends on a separate page. Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
10. Supporting Information
Supplementary material is not essential to the article but provides greater depth and background and may include tables, figures, videos, datasets, etc. This material can be submitted with your manuscript, and will appear online, without editing or typesetting. Guidelines on how to prepare this material and which formats and files sizes are acceptable can be found at: http://authorservices.com/bauthor/suppmat.asp
Please note that the provision of supplementary material is not encouraged as a general rule. It will be assessed critically by reviewers and editors and will only be accepted if it is essential.
11. SUBMISSION OF MANUSCRIPTS
Manuscripts should be submitted online at http://MC.manuscriptcentral.com/nep. Authors must supply an email address as all correspondence will be by email.
The journal to which you are submitting your manuscript employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.
All articles submitted to the Journal must comply with these instructions. Failure to do so will result in return of the manuscript and possible delay in publication.
- Submissions should be double-spaced.
- All margins should be at least 30 mm.
- All pages should be numbered consecutively in the top right-hand corner, beginning with the title page.
- Do not use Enter at the end of lines within a paragraph.
- Turn the hyphenation option off; include only those hyphens that are essential to the meaning.
- Specify any special characters used to represent non-keyboard characters.
- Take care not to use l (ell) for 1 (one), O (capital o) for 0 (zero) or ß (German esszett) for b (Greek beta).
- Use a tab, not spaces, to separate data points in tables. If you use a table editor function, ensure that each data point is contained within a unique cell (i.e. do not use enter within cells).
Each figure should be supplied as a separate file, with the figure number incorporated in the file name. For submission, low-resolution figures saved as .jpg or .bmp files should be uploaded, for ease of transmission during the review process. Upon acceptance of the article, high-resolution figures (at least 300 d.p.i.) saved as .eps or .tif files should be uploaded. Digital images supplied only as low-resolution files cannot be used.
Papers are accepted for publication in the Journal on the understanding that the content has not been published or submitted for publication elsewhere. This must be stated in the covering letter.
The covering letter must also contain an acknowledgement that all authors have contributed significantly, and that all authors are in agreement with the content of the manuscript. In keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author’s contribution to the paper is to be quantified.
Authors must declare any financial support or relationships that may pose conflict of interest by disclosing at the time of submission any financial arrangements they have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. Such information will be held in confidence while the paper is under review and will not influence the editorial decision but, if the article is accepted for publication, the Editor will usually discuss with the authors the manner in which such information is to be communicated to the reader.
If tables or figures have been reproduced from another source, a letter from the copyright holder (usually the Publisher), stating authorization to reproduce the material, must be attached to the covering letter.
It is essential that corresponding authors supply an email address to which correspondence can be emailed.
Notification of the URL from where to download a Portable Document Format (PDF) typeset page proof, associated forms and further instructions will be sent by email to the corresponding author. The purpose of the PDF proof is a final check of the layout, and of tables and figures. Alterations other than the essential correction of errors are unacceptable at PDF proof stage. The proof should be checked, and approval to publish the article should be emailed to the Publisher by the date indicated; otherwise, it may be signed off on by the Editor or held over to the next issue.
A minimum of 50 offprints will be provided upon request, at the author’s expense. These paper offprints may be ordered online. Please visit http://offprint.cosprinters.com/, fill in the necessary details and ensure that you type information in all of the required fields.
If you have queries about offprints please email email@example.com
14. PUBLICATION FEES
A charge of A$1000/US$530/¥ 64000 for the first three colour figures and A$500/US$265/¥ 32000 for each extra colour figure thereafter will be charged to the author.
15. TRACKING MANUSCRIPTS
I. Before Acceptance
Authors can track their manuscript's progress through the review process at: http://mc.manuscriptcentral.com/nep
II. After Acceptance
Author Services enables authors to track their article, once it has been accepted, through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated emails at key stages of production so they do not need to contact the Production Editor to check on progress. Visit http://authorservices.wiley.com/bauthor/ for more details on online production tracking and for a wealth of resources, including FAQs and tips on article preparation, submission and more.
16. ACCEPTED ARTICLES
Nephrology offers Accepted Articles for selected articles. Accepted Articles is a Wiley Blackwell service whereby peer-reviewed accepted articles are published online prior to their ultimate inclusion in a print or online issue. Articles published within Accepted Articles have been fully refereed, but have not been through the copy-editing, typesetting and proof correction process.
17. COPYRIGHT, LICENSING AND ONLINE OPEN
Accepted papers will be passed to Wiley's production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service( WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
FAQs about the terms and conditions of the standard copyright transfer agreements (CTA) in place for the journal, including terms regarding archiving of the accepted version of the paper, are available at: CTA Terms and Conditions FAQs.
OnlineOpen - 'Gold road' Open Access
OnlineOpen is available to authors of articles who wish to make their article freely available to all on Wiley Online Library under a Creative Commons license. In addition, authors of OnlineOpen articles are permitted to post the final, published PDF of their article on a website, institutional repository or other free public server, immediately on publication. With OnlineOpen the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made open access, known as 'gold road' open access.
OnlineOpen licenses. Authors choosing OnlineOpen retain copyright in their article and have a choice of publishing under the following Creative Commons License terms: Creative Commons Attribution License (CC BY); Creative Commons Attribution Non-Commercial License (CC BY NC); Creative Commons Attribution Non-Commercial-NoDerivs License (CC BY NC ND)
For more information about the OnlineOpen license terms and conditions click here.
WILEY JOURNALS ONLINE
Visit the Nephrology home page at wileyonlinelibrary.com/journal/nep for more information, and Wiley Online Library’s web pages for submission guidelines and digital graphics standards. Nephrology is also available online via Wiley Online Library at http://wileyonlinelibrary.com
EDITORIAL OFFICE ADDRESS
Editorial Office, Nephrology
155 Cremorne Street
Richmond, Victoria 3121
Email: firstname.lastname@example.org; tel: +61 3 9274 3136; fax: +61 3 9274 3390.